DK1068208T3 - Azatricyclo[3.3.1.1]dekanderivater og farmaceutiske sammensætninger, der indeholder dem - Google Patents
Azatricyclo[3.3.1.1]dekanderivater og farmaceutiske sammensætninger, der indeholder demInfo
- Publication number
- DK1068208T3 DK1068208T3 DK99909806T DK99909806T DK1068208T3 DK 1068208 T3 DK1068208 T3 DK 1068208T3 DK 99909806 T DK99909806 T DK 99909806T DK 99909806 T DK99909806 T DK 99909806T DK 1068208 T3 DK1068208 T3 DK 1068208T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydrogen
- substituent
- azatricyclo
- sigma
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- DIOQZVSQGTUSAI-NJFSPNSNSA-N decane Chemical class CCCCCCCCC[14CH3] DIOQZVSQGTUSAI-NJFSPNSNSA-N 0.000 title 1
- 125000001424 substituent group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052799 carbon Chemical group 0.000 abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003367 nicotinic antagonist Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/054,175 US5952339A (en) | 1998-04-02 | 1998-04-02 | Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release |
| US09/053,937 US6057446A (en) | 1998-04-02 | 1998-04-02 | Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds |
| PCT/US1999/004728 WO1999051602A1 (en) | 1998-04-02 | 1999-03-03 | Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1068208T3 true DK1068208T3 (da) | 2003-09-01 |
Family
ID=26732410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99909806T DK1068208T3 (da) | 1998-04-02 | 1999-03-03 | Azatricyclo[3.3.1.1]dekanderivater og farmaceutiske sammensætninger, der indeholder dem |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1068208B1 (enExample) |
| JP (1) | JP2002510690A (enExample) |
| KR (1) | KR100591805B1 (enExample) |
| AT (1) | ATE240331T1 (enExample) |
| AU (1) | AU2892999A (enExample) |
| BR (1) | BR9907172A (enExample) |
| CA (1) | CA2317567A1 (enExample) |
| DE (1) | DE69907894T2 (enExample) |
| DK (1) | DK1068208T3 (enExample) |
| ES (1) | ES2199561T3 (enExample) |
| MX (1) | MXPA00009634A (enExample) |
| PT (1) | PT1068208E (enExample) |
| WO (1) | WO1999051602A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953855B2 (en) | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| US6432975B1 (en) * | 1998-12-11 | 2002-08-13 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| MY145722A (en) * | 2000-04-27 | 2012-03-30 | Abbott Lab | Diazabicyclic central nervous system active agents |
| US6809105B2 (en) | 2000-04-27 | 2004-10-26 | Abbott Laboratories | Diazabicyclic central nervous system active agents |
| WO2001082978A2 (en) * | 2000-05-01 | 2001-11-08 | Targacept, Inc. | Imaging of nicotinic acetylcholine receptor subtypes |
| US7897766B2 (en) | 2005-09-23 | 2011-03-01 | Abbott Laboratories | Amino-aza-adamantane derivatives and methods of use |
| US8314119B2 (en) | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
| MX2009010175A (es) * | 2007-03-23 | 2009-10-12 | Abbott Lab | Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos. |
| EP2497771A1 (en) * | 2007-03-23 | 2012-09-12 | Abbott Laboratories | 4 -substituted azaadamantane derivatives and methods of use thereof |
| SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| EP2619205B1 (en) | 2010-09-23 | 2017-05-17 | AbbVie Bahamas Ltd. | Monohydrate of an azaadamantane derivative |
| US9724340B2 (en) | 2015-07-31 | 2017-08-08 | Attenua, Inc. | Antitussive compositions and methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL107184A (en) * | 1992-10-09 | 1997-08-14 | Abbott Lab | Heterocyclic ether compounds that enhance cognitive function |
| US5597919A (en) * | 1995-01-06 | 1997-01-28 | Dull; Gary M. | Pyrimidinyl or Pyridinyl alkenyl amine compounds |
| US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
| US5583140A (en) * | 1995-05-17 | 1996-12-10 | Bencherif; Merouane | Pharmaceutical compositions for the treatment of central nervous system disorders |
| JP3510937B2 (ja) * | 1995-06-05 | 2004-03-29 | ポリプラスチックス株式会社 | 耐熱性ポリエステルアミドスルフィド樹脂及びその組成物 |
| US6022868A (en) * | 1995-06-29 | 2000-02-08 | Novo Nordisk Als | Substituted azacyclic or azabicyclic compounds |
| EP0853621A1 (en) * | 1995-09-22 | 1998-07-22 | Novo Nordisk A/S | Novel substituted azacyclic or azabicyclic compounds |
-
1999
- 1999-03-03 BR BR9907172-0A patent/BR9907172A/pt not_active Application Discontinuation
- 1999-03-03 ES ES99909806T patent/ES2199561T3/es not_active Expired - Lifetime
- 1999-03-03 EP EP99909806A patent/EP1068208B1/en not_active Expired - Lifetime
- 1999-03-03 AT AT99909806T patent/ATE240331T1/de not_active IP Right Cessation
- 1999-03-03 WO PCT/US1999/004728 patent/WO1999051602A1/en not_active Ceased
- 1999-03-03 KR KR1020007008963A patent/KR100591805B1/ko not_active Expired - Fee Related
- 1999-03-03 DK DK99909806T patent/DK1068208T3/da active
- 1999-03-03 AU AU28929/99A patent/AU2892999A/en not_active Abandoned
- 1999-03-03 JP JP2000542323A patent/JP2002510690A/ja active Pending
- 1999-03-03 CA CA002317567A patent/CA2317567A1/en not_active Abandoned
- 1999-03-03 PT PT99909806T patent/PT1068208E/pt unknown
- 1999-03-03 MX MXPA00009634A patent/MXPA00009634A/es not_active IP Right Cessation
- 1999-03-03 DE DE69907894T patent/DE69907894T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR100591805B1 (ko) | 2006-06-26 |
| DE69907894D1 (de) | 2003-06-18 |
| ES2199561T3 (es) | 2004-02-16 |
| EP1068208B1 (en) | 2003-05-14 |
| EP1068208A1 (en) | 2001-01-17 |
| CA2317567A1 (en) | 1999-10-14 |
| KR20010052173A (ko) | 2001-06-25 |
| AU2892999A (en) | 1999-10-25 |
| JP2002510690A (ja) | 2002-04-09 |
| WO1999051602A1 (en) | 1999-10-14 |
| BR9907172A (pt) | 2000-10-10 |
| DE69907894T2 (de) | 2004-03-11 |
| MXPA00009634A (es) | 2005-06-20 |
| PT1068208E (pt) | 2003-09-30 |
| ATE240331T1 (de) | 2003-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003222450A1 (en) | Stabilized ascorbic acid derivatives | |
| CZ142195A3 (en) | Injectable composition containing derivatives of taxan group | |
| CA2302445A1 (en) | New taxane derivatives | |
| IL114726A0 (en) | Noribogaine derivatives and pharmaceutical compositions containing the same | |
| CA2400804A1 (en) | Stable emulsion compositions of cycloalkene derivatives | |
| BR9907172A (pt) | Derivados de azatriciclo[3.3.1.1] decano e composições farmacêuticas contendo-os | |
| CA2277877A1 (en) | Nitric oxide synthase inhibitors | |
| WO1999033858A3 (en) | Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use | |
| AP9701039A0 (en) | Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one. | |
| WO2004098518A3 (en) | Pyrazole-amide compounds useful as kinase inhibitors | |
| CA2113229A1 (en) | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof | |
| WO2004071440A3 (en) | Thiazolyl-based compounds useful as kinase inhibitors | |
| UA41291C2 (uk) | ФТОРОВАНІ ПОХІДНІ 17<font face="Symbol">b</font>-ЗАМІЩЕНОГО-4-AЗA-5<font face="Symbol">a-</font>АНДРОСТАН-3-ОНУ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ | |
| MX9701819A (es) | Dihidrobenzofurano y compuestos relacionados, utiles como agentes antiiflamatorios. | |
| IL136359A0 (en) | Dihydrobenzofuran derivatives and pharmaceutical compositions containing the same | |
| WO1999009965A3 (en) | Anti-inflammatory agent | |
| CA2187110A1 (en) | Benzamide derivative, compositions containing said derivative and use thereof | |
| DK1066287T3 (da) | Azatricykliske forbindelser | |
| WO2002007677A3 (en) | Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder | |
| IL127379A0 (en) | Dihydrobenzopyran and related compounds useful as anti-inflammatory agents | |
| AU693682B2 (en) | Cancerous metastasis inhibitor | |
| EP1182192A4 (en) | 4-HYDROXYPIPERIDINE DERIVATIVES WITH ANTI-ARRHYTHMIC EFFECT | |
| AU8889998A (en) | Water soluble analogs and prodrugs of paclitaxel | |
| WO2001051004A3 (en) | Anti-cancer agent containing naphthoquinone compound | |
| EP0335979A4 (en) | Thienopyrimidine derivatives |